Belluscura Secures Funding, on Track for FDA Clearance

Hello Tekcapital community,

We hope you’re doing well! We have some news on our portfolio company, Belluscura plc, that we’re extremely pleased to report.

Belluscura has recently received a commitment to invest a further £725,000 into the company, in addition to its successful crowdfund, which concluded last month. Furthermore, the status of their patented X-Plor oxygen concentrator is expected to achieve FDA clearance by the end of 2019, and be commercially available in H1 2020. Read the article on Morningstar.

Leave a comment